本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Revolution Medicines, Inc.

41.19
+0.55001.35%
成交量:36.31万
成交额:1,498.27万
市值:76.58亿
市盈率:-11.51
高:41.65
开:41.26
低:40.99
收:40.64
数据加载中...
2023/08/01

重要事件披露

Form 8-K - Current report
2023/08/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/01

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/08/01

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/08/01

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/07/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/01

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/06/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/16

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/06/10

重要事件披露

Form 8-K - Current report
2023/05/08

重要事件披露

8-K - Current report
2023/05/08

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/07

重要事件披露

8-K - Current report
2023/02/27

重要事件披露

8-K - Current report
2023/02/27

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/27

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals